Uncategorised - European Medical Journal

NICE Turns Down Breakthrough Drugs for Alzheimer’s Patients

Despite the setback, hope remains, with 138 dementia drugs currently in trials, experts say more effective, safer options may soon emerge.

25 Jun 2025

Why Are You Still Avoiding PD in Older Adults? An Interactive Case Study

For elderly patients, survival duration between hemodialysis and peritoneal dialysis, even when statistically significant, is usually in…

From Bench to Bedside and Back: An Interview with Joshua Richter

Joshua Richter – Associate Professor, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. What initially…

Fungal Threats Rising as Climate Changes

Climate change is accelerating the emergence and spread of dangerous fungal infections, expanding their range and resistance in ways that could reshape global public health.

Key Appointments Being Missed After Adolescent and Young Adult Cancer

A new study reveals significant gaps in follow-up care among survivors of adolescent and young adult (AYA)–onset cancers, with nearly one in five missing all oncology specialty visits during the surveillance period.

Weight Loss Reduces Inflammation in Metabolic Liver Disease

Discover a study that found that individuals with higher baseline IL-1β levels experienced greater improvements in liver health following weight loss.

New Insights into VMAT2 Use for Child Movement Disorders

VMAT2 inhibitors may offer effective symptom relief for pediatric hyperkinetic movement disorders, according to a new retrospective study reviewing over a decade of clinical use.

Interview: Rainer Oberbauer

I’ve been in the field for almost 30 years now. I started by chance after my postdoctoral training. I became interested in kidney…

Bronchoscopy Beats CT for Lung Nodule Precision

Electromagnetic navigation bronchoscopy (ENB)-guided dye marking offers a safer, faster alternative to CT-guided lung puncture for preoperative localization of multiple ipsilateral pulmonary nodules, according to a new retrospective cohort study.

EAN 2025: Blood Biomarker sNfL Predicts MS Relapses Up to a Year in Advance

Blood biomarker sNfL predicts MS relapses up to a year in advance, offering new hope for earlier intervention.